STEPHANIE K DONDERO
Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology ARMONK, NY NPI 1578978656
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology NY Aurinia Pharma U.S., Inc. All categories
General Payments — all program years on this page
$2,577.43
- Category: General Payments
- Program years: PY2018–2024
- Record count: 68
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $311.03 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $231.04 | 6 |
| Education | $79.99 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Aurinia Pharma U.S., Inc. | $121.84 | 1 |
| Janssen Biotech, Inc. | $79.99 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $58.04 | 3 |
| ABBVIE INC. | $28.85 | 1 |
| Acerta Pharma LLC | $22.31 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078402634 | Janssen Biotech, Inc. | $79.99 | 04/24/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1086838309 | Novartis Pharmaceuticals Corporation | $15.48 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086838311 | Novartis Pharmaceuticals Corporation | $22.73 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086838313 | Novartis Pharmaceuticals Corporation | $19.83 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103652104 | ABBVIE INC. | $28.85 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104564586 | AstraZeneca Pharmaceuticals LP | $22.31 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150679307 | Aurinia Pharma U.S., Inc. | $121.84 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.